14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.11 $8.20 Thursday, 2nd May 2024 GLUE stock ended at $5.60. This is 5.72% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 10.84% from a day low at $5.35 to a day high of $5.93.
90 days $4.19 $8.84
52 weeks $2.44 $8.84

Historical Monte Rosa Therapeutics, Inc. prices

Date Open High Low Close Volume
Feb 21, 2024 $5.50 $5.60 $5.37 $5.50 61 733
Feb 20, 2024 $5.85 $5.99 $5.42 $5.55 95 335
Feb 16, 2024 $5.55 $6.56 $5.55 $5.96 152 097
Feb 15, 2024 $5.12 $5.55 $4.91 $5.53 221 925
Feb 14, 2024 $4.35 $4.81 $4.29 $4.76 139 229
Feb 13, 2024 $4.54 $4.70 $4.19 $4.26 217 201
Feb 12, 2024 $4.85 $4.95 $4.42 $4.66 263 405
Feb 09, 2024 $4.75 $4.91 $4.57 $4.87 147 437
Feb 08, 2024 $4.63 $4.74 $4.54 $4.69 79 234
Feb 07, 2024 $5.06 $5.06 $4.63 $4.63 87 147
Feb 06, 2024 $4.80 $5.11 $4.80 $5.07 74 560
Feb 05, 2024 $4.60 $4.89 $4.60 $4.81 74 380
Feb 02, 2024 $4.89 $4.98 $4.61 $4.72 75 741
Feb 01, 2024 $5.34 $5.34 $4.93 $4.95 133 110
Jan 31, 2024 $5.26 $5.70 $5.17 $5.30 62 553
Jan 30, 2024 $5.79 $5.81 $5.21 $5.32 122 742
Jan 29, 2024 $5.46 $5.99 $5.32 $5.88 83 173
Jan 26, 2024 $5.83 $5.88 $5.41 $5.43 52 982
Jan 25, 2024 $5.61 $5.82 $5.40 $5.79 63 946
Jan 24, 2024 $5.76 $5.84 $5.33 $5.47 77 312
Jan 23, 2024 $5.59 $5.80 $5.52 $5.61 73 687
Jan 22, 2024 $5.12 $5.52 $5.12 $5.51 210 341
Jan 19, 2024 $5.15 $5.20 $4.83 $5.05 102 714
Jan 18, 2024 $5.37 $5.37 $4.94 $5.12 110 301
Jan 17, 2024 $5.33 $5.51 $5.12 $5.29 260 922
Click to get the best stock tips daily for free!

About Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics. Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, ... GLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT